The filing confirms a large holder crossed the 10% threshold in September, but no recent trading activity is disclosed. Monitor future 13D filings for any activist intent or changes in position.
BIAF drugs
BIAF drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 19 $1.85entry
- T+1 · 2d ago −10.81%α −7.17% · $1.65
- T+5 · in 5d Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
HRT Financial LP filed a Form 3 initial statement of beneficial ownership, disclosing a 10%+ stake in bioAffinity Technologies as of September 22, 2026. The filing reports 116,782 shares of common stock and 1,183 warrants exercisable for fractional shares, but does not provide the percentage ownership or total economic exposure.
Key Facts
- HRT Financial LP became beneficial owner of more than 10% of BIAF common stock on September 22, 2026.
- HRT directly holds 116,782 shares of common stock.
- HRT holds 1,183 warrants, each exercisable for 1/450 of a share of common stock at an exercise price of $2.6289 per whole share (adjusted for reverse splits), expiring June 22, 2027.
- The filing is an initial statement of beneficial ownership (Form 3), not a trading or change-in-ownership event.
Financial Impact
HRT holds 116,782 common shares plus warrants for approximately 2.63 additional shares. At a $4M market cap, the stake value is not stated but the share count suggests a material position.
Risk Factors
- No percentage ownership or total value is disclosed, making the exact economic exposure unclear.
- Warrant terms include a fractional share conversion and reverse-split adjustments, adding complexity to dilution calculations.
- The filing is retrospective (September 22 event) and does not indicate current intent or future actions.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001475597-26-000253 |
| Document: 0001475597-26-000253-index.html | 0001475597-26-000253 |
| Document: 0001475597-26-000253.txt | 0001475597-26-000253 |
Track record
37 reports on BIAF
4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +66.50% at T+60 after the Jul 31, 2026 report. 12 of 16 went positive at some point.
Filters
- Nov 19, 20262d ago SC 13G Neutral 4/10 Entry $2.01 Now $1.65 −17.91% settles Feb 19
- Nov 19, 20262d ago Insider Buy Bullish 5/10 Entry $2.01 Now $1.65 −17.91% settles Feb 19
- Nov 19, 20262d ago 3 Neutral 3/10 Viewing Entry $1.85 Now $1.65 −10.81% settles Feb 18
- Nov 19, 20262d ago 8-K Neutral 2/10 Entry $1.85 Now $1.65 −10.81% settles Feb 18
- Nov 17, 20264d ago 8-K Neutral 3/10 Entry $1.93 Now $1.65 −14.51% settles Feb 16
- Nov 6, 202615d ago 8-K Bearish 5/10 Entry $2.26 Now $1.65 +26.99% settles Feb 5
- Nov 3, 202618d ago 424B5 Bearish 6/10 Entry $2.93 Now $1.65 +43.69% settles Feb 2
- Nov 2, 202619d ago 424B5 Bearish 5/10 Entry $3.19 Now $1.65 +48.28% settles Feb 1
- Oct 29, 202623d ago 8-K Neutral 2/10 Entry $3.03 Now $1.65 −45.54% settles Jan 27
- Oct 23, 202629d ago DEF 14A Neutral 5/10 Entry $2.83 Now $1.65 −41.70% settles Jan 22
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers